RARA CRAFT DATABASE for FDA Medical Devices
510(k)K252922

FDA DEVICE FACTS

Neosoma Brain Mets

Neosoma, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

AI/ML
DECISION DATEDecember 17, 2025PRODUCT CODEQIHCLINICAL AREARadiology

Indications for use

The Neosoma software uses an artificial intelligence algorithm (i.e., deep learning neural networks) to contour (segment) known or previously diagnosed brain tumors on MRI images for qualified and trained medical professionals. The technology is meant for informational purposes only and not intended to replace the clinician’s current standard practice of manual contouring. The software does not alter the original MRI image, nor is it intended to be used to detect tumors for diagnosis. The software is intended to be used on adult patients only. When using the Neosoma software in a radiation oncology planning workflow, or other clinical workflows, it is intended for generating Gross Tumor Volume (GTV) contours. For all clinical workflows, medical professionals must finalize (confirm or modify) the contours generated by the Neosoma software, as necessary, using an external platform available at the facility that supports DICOM viewing/editing functions, such as image visualization software and treatment planning system.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 16, 2026